Are Medical Stocks Lagging Tactile Systems Technology (TCMD) This Year?
Werte in diesem Artikel
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Tactile Systems Technology (TCMD) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.Tactile Systems Technology is one of 947 individual stocks in the Medical sector. Collectively, these companies sit at #3 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Tactile Systems Technology is currently sporting a Zacks Rank of #2 (Buy).Over the past 90 days, the Zacks Consensus Estimate for TCMD's full-year earnings has moved 26.5% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.Our latest available data shows that TCMD has returned about 51.4% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 8.8% on average. This means that Tactile Systems Technology is outperforming the sector as a whole this year.One other Medical stock that has outperformed the sector so far this year is Aveanna Healthcare (AVAH). The stock is up 102.9% year-to-date.For Aveanna Healthcare, the consensus EPS estimate for the current year has increased 41.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).To break things down more, Tactile Systems Technology belongs to the Medical - Instruments industry, a group that includes 81 individual companies and currently sits at #81 in the Zacks Industry Rank. This group has gained an average of 6% so far this year, so TCMD is performing better in this area. In contrast, Aveanna Healthcare falls under the Medical - Outpatient and Home Healthcare industry. Currently, this industry has 15 stocks and is ranked #40. Since the beginning of the year, the industry has moved +12.5%.Investors with an interest in Medical stocks should continue to track Tactile Systems Technology and Aveanna Healthcare. These stocks will be looking to continue their solid performance.Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tactile Systems Technology, Inc. (TCMD): Free Stock Analysis Report Aveanna Healthcare Holdings Inc. (AVAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Tactile Systems Technology und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Tactile Systems Technology
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Tactile Systems Technology
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks